Nasdaq:US$13.65 (-0.24) | HKEX:HK$21.10 (-0.50) | AIM:£2.23 (-0.06)
News & Presentations
Previous Article   |   Next Article
Presentations | 6 Jun 2022

ASCO2022: Surufatinib in US Patients with Soft Tissue Sarcoma